Tesofensine

Description

Buy Tesofensine Online

Tesofensine is an investigational weight-management compound that inhibits the reuptake of norepinephrine, dopamine, and serotonin. Human clinical trials have demonstrated significant effects on body weight and appetite.

Product Information

Tesofensine is a triple monoamine reuptake inhibitor originally investigated in neurological disorders and subsequently studied for obesity. It is not an approved general-purpose weight-loss medication in the United States.

How Does It Work?

Tesofensine inhibits presynaptic reuptake of norepinephrine, dopamine, and serotonin. This alters central neurotransmission and appears to reduce appetite while also influencing energy metabolism.

Benefits

Weight Reduction

A 24-week randomized trial in adults with obesity found substantially greater weight loss with tesofensine than placebo, with effects increasing across the studied dose range.

Appetite Suppression

Human studies found increased satiety and fullness together with reduced prospective food intake. Appetite effects appear to contribute substantially to weight loss.

Fat-Oxidation Research

Clinical research has reported increased fat oxidation under tesofensine treatment, although the full mechanism behind weight loss remains unresolved.

Quality-of-Life Research

Clinical obesity studies have examined changes in quality of life alongside weight loss, making tesofensine relevant to broader obesity-treatment research.

Side Effects

Dry mouth, nausea, constipation, diarrhea, insomnia, increased heart rate, and potential blood-pressure effects have been reported. Psychiatric tolerability also requires consideration.

Dosage

A phase II obesity trial studied 0.25, 0.5, and 1.0 mg once daily for 24 weeks. These are clinical-study doses, not individualized treatment recommendations.

Where to Buy Tesofensine

Readers should distinguish experimental tesofensine products from approved prescription medicines and evaluate independent product testing.

References

Astrup A, et al. Effect of tesofensine on bodyweight loss, body composition, and quality of life in obese patients: a randomised, double-blind, placebo-controlled trial. Lancet. 2008;372(9653):1906-1913.

PubMed — Tesofensine Phase II Trial

Purerawz Disclaimer

Purerawz does not sell, manufacture, stock, dispense, or directly supply any of the products discussed on this website. Purerawz is an independent information and affiliate platform. Where available, links may direct readers to independent third-party suppliers, and Purerawz may receive a commission from qualifying purchases at no additional cost to the reader.

The information on these pages is provided for educational and informational purposes only. Dosage figures may reflect published research protocols or reported community use and should not be interpreted as personalized medical instructions. Research findings, particularly animal and early-stage studies, do not necessarily translate into established human benefits or safety.